心通医疗-B(02160)：VITAFLOW LIBERTY® FLEX获国家药监局批准注册

智通财经2024-12-17

智通财经APP讯，心通医疗-B(02160)发布公告，于2024年12月16日，集团自主研发的第三代经导管主动脉瓣植入术(TAVI)产品VitaFlow Liberty® Flex经导管主动脉瓣可回收可控弯输送系统(“VitaFlow Liberty® Flex”)获得中国国家药品监督管理局颁发的注册批准。VitaFlow Liberty® Flex为VitaFlow Liberty®输送系统的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2492396932?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-17 22:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492396932","market":"hk","top_or_hot":-1,"title":"心通医疗-B(02160)：VITAFLOW LIBERTY® FLEX获国家药监局批准注册","media":"智通财经","content":"<div>\n<p>智通财经APP讯，心通医疗-B(02160)发布公告，于2024年12月16日，集团自主研发的第三代经导管主动脉瓣植入术(TAVI)产品VitaFlow Liberty® Flex经导管主动脉瓣可回收可控弯输送系统(“VitaFlow Liberty® Flex”)获得中国国家药品监督管理局颁发的注册批准。VitaFlow Liberty® Flex为VitaFlow Liberty®输送系统的...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1226243.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>心通医疗-B(02160)：VITAFLOW LIBERTY® FLEX获国家药监局批准注册</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n心通医疗-B(02160)：VITAFLOW LIBERTY® FLEX获国家药监局批准注册\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-17 22:55 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1226243.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，心通医疗-B(02160)发布公告，于2024年12月16日，集团自主研发的第三代经导管主动脉瓣植入术(TAVI)产品VitaFlow Liberty® Flex经导管主动脉瓣可回收可控弯输送系统(“VitaFlow Liberty® Flex”)获得中国国家药品监督管理局颁发的注册批准。VitaFlow Liberty® Flex为VitaFlow Liberty®输送系统的...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1226243.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4145","symbol_name":"电子制造服务","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1226243.html","article_id":"2492396932","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492396932","pubTimestamp":1734447355,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，心通医疗-B 发布公告，于2024年12月16日，集团自主研发的第三代经导管主动脉瓣植入术产品VitaFlow Liberty Flex经导管主动脉瓣可回收可控弯输送系统获得中国国家药品监督管理局颁发的注册批准。同时 VitaFlow Liberty Flex实现了瓣膜释放的交界对齐，保护冠脉通路，为未来冠脉介入预留空间。此外，得益于公司产品全生命周期管理理念在研发阶段的深度实践，VitaFlow Liberty Flex将有助于公司进一步降低生产成本。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4145":"电子制造服务","LU0472753341.HKD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (HKD) ACC","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU0175139822.USD":"AB FCP I Global Equity Blend A USD","LU0057025933.USD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (USD) ACC","LU0689626769.HKD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (HKD) ACC","BK1100":"医疗保健设备","LU0511384066.AUD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (AUDHDG) ACC","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","02160":"心通医疗-B","BK1574":"生物医药B类股","BK4585":"ETF&股票定投概念","LU0289960550.SGD":"AB FCP I - GLOBAL EQUITY BLEND PORTFOLIO 'A' (SGD) ACC","LU0289961442.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (SGD) ACC","BK1583":"高瓴概念","LU0069063385.USD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (USD) ACC","LU1303367103.USD":"摩根大通多经理另类基金 A (acc)","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","BK4588":"碎股","LU0963586101.USD":"ALLIANZ GLOBAL SMALL CAP EQUITY \"AT\" ACC","LU2098885051.SGD":"JPMorgan Funds - Multi-Manager Alternatives A (acc) SGD","FLEX":"伟创力国际","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","BK4512":"苹果概念","LU0124676726.USD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (USD) ACC"},"translate_title":"Xintong Medical-B (02160): VITAFLOW LIBERTY ® FLEX was approved for registration by the State Food and Drug Administration","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FLEX":1,"02160":1},"content_text":"智通财经APP讯，心通医疗-B(02160)发布公告，于2024年12月16日，集团自主研发的第三代经导管主动脉瓣植入术(TAVI)产品VitaFlow Liberty® Flex经导管主动脉瓣可回收可控弯输送系统(“VitaFlow Liberty® Flex”)获得中国国家药品监督管理局颁发的注册批准。VitaFlow Liberty® Flex为VitaFlow Liberty®输送系统的升级款产品，可与集团已获批的主动脉瓣膜配合使用，其传承了VitaFlow Liberty®输送系统的所有优势，并创新性地增加了3D空间调弯功能。其独有的内管调弯技术可使瓣膜在释放过程中保持同轴，植入更稳定精准，过弓以及跨瓣也更顺畅安全。同时 VitaFlow Liberty® Flex实现了瓣膜释放的交界对齐，保护冠脉通路，为未来冠脉介入预留空间。该产品为医生提供更优异的易用性体验，进一步提升手术效率和安全性，并减少手术并发症发生。此外，得益于公司产品全生命周期管理理念在研发阶段的深度实践，VitaFlow Liberty® Flex将有助于公司进一步降低生产成本。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.7","shortVersion":"4.31.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492396932"}